Skip to content
PubMed This is a summary of 61 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 61 referenced papers

Top Authors

Peter S. Spencer
Oregon Health & Science University
Glen E. Kisby
Pacific Northwest University of Health Sciences
Valerie S. Palmer
Oregon Health & Science University
Bert M. Verheijen
University of Southern California
Kiyomitsu Oyanagi
Shinshu University
Yasumasa Kokubo
Mie University
John Charles Steele
Memorial Hospital
Masato Hasegawa
Tokyo Metropolitan Institute of Medical Science
Mari Yoshida
Aichi Medical University
Fred W. van Leeuwen
Maastricht University

Top Institutions

Ranked by publications Top 10 institutions
02

Pacific Northwest University of Health Sciences

Yakima, United States

10 papers
04

Shinshu University

Matsumoto, Japan

7 papers
Contributors Kiyomitsu Oyanagi
07

Mie University

Tsu, Japan

7 papers
08

Memorial Hospital

York, United States

5 papers
Contributors John Charles Steele

References

References (61)
  1. 1

    Defining neurodegeneration on Guam by targeted genomic sequencing.

    Steele JC, Guella I, Szu-Tu C, et al.

    Annals of neurology 2015; (77(3)):458-68 doi:10.1002/ana.24346.

    PMID: 25558820
  2. 2

    Clinical varieties and epidemiological aspects of amyotrophic lateral sclerosis in the Caribbean island of Guadeloupe: A new focus of ALS associated with Parkinsonism.

    Lannuzel A, Mecharles S, Tressières B, et al.

    Amyotrophic lateral sclerosis & frontotemporal degeneration 2015; (16(3-4)):216-23 doi:10.3109/21678421.2014.992026.

    PMID: 25646866
  3. 3

    A unique retinal epitheliopathy is associated with amyotrophic lateral sclerosis/Parkinsonism-Dementia complex of Guam.

    Steele JC, Wresch R, Hanlon SD, et al.

    Movement disorders : official journal of the Movement Disorder Society 2015; (30(9)):1271-5 doi:10.1002/mds.26264.

    PMID: 26153661
  4. 4

    The frontotemporal dementia-motor neuron disease continuum.

    Burrell JR, Halliday GM, Kril JJ, et al.

    Lancet (London, England) 2016; (388(10047)):919-31.

    PMID: 26987909
  5. 5

    Seeking environmental causes of neurodegenerative disease and envisioning primary prevention.

    Spencer PS, Palmer VS, Kisby GE

    Neurotoxicology 2016; (56()):269-283 doi:10.1016/j.neuro.2016.03.017.

    PMID: 27050202
  6. 6

    Care management in amyotrophic lateral sclerosis.

    Soriani MH, Desnuelle C

    Revue neurologique 2017; (173(5)):288-299 doi:10.1016/j.neurol.2017.03.031.

    PMID: 28461024
  7. 7

    A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.

    Chernoff N, Hill DJ, Diggs DL, et al.

    Journal of toxicology and environmental health. Part B, Critical reviews 2017; (20(4)):1-47 doi:10.1080/10937404.2017.1297592.

    PMID: 28598725
  8. 8

    Supportive care needs of patients with amyotrophic lateral sclerosis/motor neuron disease and their caregivers: A scoping review.

    Oh J, Kim JA

    Journal of clinical nursing 2017; (26(23-24)):4129-4152 doi:10.1111/jocn.13945.

    PMID: 28681543
  9. 9

    'Hummingbird' Sign in a Patient with Guam Parkinsonism-Dementia Complex.

    Yeo T, Tan LC

    Journal of movement disorders 2017; (10(3)):145-148 doi:10.14802/jmd.17025.

    PMID: 28782342
  10. 10

    A migration case of Kii amyotrophic lateral sclerosis/parkinsonism dementia complex with the shortest stay in the endemic area and the longest incubation to develop the disease.

    Tsunoda K, Yamashita T, Shimada H, et al.

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2017; (46()):64-67 doi:10.1016/j.jocn.2017.08.057.

    PMID: 28890043
  11. 11

    Motor learning in people with Parkinson's disease: Implications for fall prevention across the disease spectrum.

    Paul SS, Dibble LE, Peterson DS

    Gait & posture 2018; (61()):311-319 doi:10.1016/j.gaitpost.2018.01.026.

    PMID: 29413803
  12. 12

    ERLIN1 mutations cause teenage-onset slowly progressive ALS in a large Turkish pedigree.

    Tunca C, Akçimen F, Coşkun C, et al.

    European journal of human genetics : EJHG 2018; (26(5)):745-748 doi:10.1038/s41431-018-0107-5.

    PMID: 29453415
  13. 13

    Dysfunction of Protein Quality Control in Parkinsonism-Dementia Complex of Guam.

    Verheijen BM, Oyanagi K, van Leeuwen FW

    Frontiers in neurology 2018; (9()):173 doi:10.3389/fneur.2018.00173.

    PMID: 29615966
  14. 14

    Circumstances and Signs of Approaching Death in Patients With Amyotrophic Lateral Sclerosis Undergoing Noninvasive Ventilation in Home Care Settings.

    Ushikubo M

    The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses 2018; (50(3)):182-186 doi:10.1097/JNN.0000000000000362.

    PMID: 29652733
  15. 15

    Cerebrovascular inflammation is associated with tau pathology in Guam parkinsonism dementia.

    Majerova P, Garruto RM, Kovac A

    Journal of neural transmission (Vienna, Austria : 1996) 2018; (125(7)):1013-1025 doi:10.1007/s00702-018-1883-3.

    PMID: 29700607
  16. 16

    Respiratory Failure in Amyotrophic Lateral Sclerosis.

    Niedermeyer S, Murn M, Choi PJ

    Chest 2019; (155(2)):401-408 doi:10.1016/j.chest.2018.06.035.

    PMID: 29990478
  17. 17

    The analysis of underivatized β-Methylamino-L-alanine (BMAA), BAMA, AEG & 2,4-DAB in Pteropus mariannus mariannus specimens using HILIC-LC-MS/MS.

    Foss AJ, Chernoff N, Aubel MT

    Toxicon : official journal of the International Society on Toxinology 2018; (152()):150-159 doi:10.1016/j.toxicon.2018.07.028.

    PMID: 30102919
  18. 18

    Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study.

    Calvo A, Chiò A, Pagani M, et al.

    Journal of neurology 2019; (266(7)):1633-1642 doi:10.1007/s00415-019-09305-0.

    PMID: 30949819
  19. 19

    Advance care planning in progressive neurological diseases: lessons from ALS.

    Seeber AA, Pols AJ, Hijdra A, et al.

    BMC palliative care 2019; (18(1)):50 doi:10.1186/s12904-019-0433-6.

    PMID: 31196046
  20. 20

    Hypothesis: Etiologic and Molecular Mechanistic Leads for Sporadic Neurodegenerative Diseases Based on Experience With Western Pacific ALS/PDC.

    Spencer PS

    Frontiers in neurology 2019; (10()):754 doi:10.3389/fneur.2019.00754.

    PMID: 31417480
  21. 21

    Clinical usefulness of scales for evaluating cognitive impairment in patients with amyotrophic lateral sclerosis.

    Nagashima K, Makioka K, Fujita Y, et al.

    Journal of the neurological sciences 2019; (405()):116414 doi:10.1016/j.jns.2019.07.032.

    PMID: 31419623
  22. 22

    Activation of the Unfolded Protein Response and Proteostasis Disturbance in Parkinsonism-Dementia of Guam.

    Verheijen BM, Lussier C, Müller-Hübers C, et al.

    Journal of neuropathology and experimental neurology 2020; (79(1)):34-45 doi:10.1093/jnen/nlz110.

    PMID: 31750913
  23. 23

    Top Ten Tips Palliative Care Clinicians Should Know About Amyotrophic Lateral Sclerosis.

    Everett EA, Pedowitz E, Maiser S, et al.

    Journal of palliative medicine 2020; (23(6)):842-847 doi:10.1089/jpm.2020.0046.

    PMID: 32101493
  24. 24

    Emerging Drugs for the Treatment of Amyotrophic Lateral Sclerosis: A Focus on Recent Phase 2 Trials.

    Barp A, Gerardi F, Lizio A, et al.

    Expert opinion on emerging drugs 2020; (25(2)):145-164 doi:10.1080/14728214.2020.1769067.

    PMID: 32456491
  25. 25

    Amyotrophic lateral sclerosis: a clinical review.

    Masrori P, Van Damme P

    European journal of neurology 2020; (27(10)):1918-1929 doi:10.1111/ene.14393.

    PMID: 32526057
  26. 26

    Etiology of Retinal and Cerebellar Pathology in Western Pacific Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex.

    Spencer PS

    Eye and brain 2020; (12()):97-104 doi:10.2147/EB.S260823.

    PMID: 32765151
  27. 27

    Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases.

    Quinn C, Elman L

    Continuum (Minneapolis, Minn.) 2020; (26(5)):1323-1347 doi:10.1212/CON.0000000000000911.

    PMID: 33003004
  28. 28

    Western Pacific ALS-PDC: Evidence implicating cycad genotoxins.

    Spencer PS, Palmer VS, Kisby GE

    Journal of the neurological sciences 2020; (419()):117185 doi:10.1016/j.jns.2020.117185.

    PMID: 33190068
  29. 29

    Kampō medicine and Muro disease (Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex): Postscript and Historical Footnote.

    Spencer PS, Palmer VS, Kihira T, et al.

    eNeurologicalSci 2021; (22()):100308 doi:10.1016/j.ensci.2020.100308.

    PMID: 33426315
  30. 30

    Multidisciplinary care in Amyotrophic Lateral Sclerosis: a systematic review and meta-analysis.

    de Almeida FEO, do Carmo Santana AK, de Carvalho FO

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2021; (42(3)):911-923 doi:10.1007/s10072-020-05011-2.

    PMID: 33443670
  31. 31

    Diagnostics of Amyotrophic Lateral Sclerosis: Up to Date.

    Štětkářová I, Ehler E

    Diagnostics (Basel, Switzerland) 2021; (11(2)) doi:10.3390/diagnostics11020231.

    PMID: 33546386
  32. 32

    A Rare Case of Amyotrophic Lateral Sclerosis With Asymmetrical Phrenic Nerve Lesion Presenting With Acute Respiratory Failure as an Initial Manifestation.

    Blanco R, Pichardo J, Abdullah H

    Cureus 2021; (13(1)):e12547 doi:10.7759/cureus.12547.

    PMID: 33564541
  33. 33

    Exploring the experiences of living with Lewy body dementia: An integrative review.

    Bentley A, Morgan T, Salifu Y, Walshe C

    Journal of advanced nursing 2021; (77(12)):4632-4645 doi:10.1111/jan.14932.

    PMID: 34146346
  34. 34

    Lytico-bodig in Guam: Historical links between diet and illness during and after Spanish colonization.

    Giménez-Roldán S, Steele JC, Palmer VS, Spencer PS

    Journal of the history of the neurosciences 2021; (30(4)):335-374 doi:10.1080/0964704X.2021.1885946.

    PMID: 34197260
  35. 35

    Interventions for preventing falls and fall-related fractures in community-dwelling older adults: A systematic review and network meta-analysis.

    Dautzenberg L, Beglinger S, Tsokani S, et al.

    Journal of the American Geriatrics Society 2021; (69(10)):2973-2984 doi:10.1111/jgs.17375.

    PMID: 34318929
  36. 36

    Parkinsonism and motor neuron disorders: Lessons from Western Pacific ALS/PDC.

    Spencer PS

    Journal of the neurological sciences 2022; (433()):120021 doi:10.1016/j.jns.2021.120021.

    PMID: 34635325
  37. 37

    An immigrant family with Kii amyotrophic lateral sclerosis/parkinsonism-dementia complex.

    Kokubo Y, Morimoto S, Sasaki R, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022; (43(2)):1423-1425 doi:10.1007/s10072-021-05737-7.

    PMID: 34779964
  38. 38

    Genotoxic Damage During Brain Development Presages Prototypical Neurodegenerative Disease.

    Kisby GE, Spencer PS

    Frontiers in neuroscience 2021; (15()):752153 doi:10.3389/fnins.2021.752153.

    PMID: 34924930
  39. 39

    Embedded Palliative Care for Amyotrophic Lateral Sclerosis: A Pilot Program and Lessons Learned.

    Fahrner-Scott K, Zapata C, O'Riordan DL, et al.

    Neurology. Clinical practice 2022; (12(1)):68-75 doi:10.1212/CPJ.0000000000001124.

    PMID: 36157626
  40. 40

    Development of a behavioural framework for dementia care partners' fall risk management.

    Zhou Y, Berridge C, Hooyman NR, et al.

    BMC geriatrics 2022; (22(1)):975 doi:10.1186/s12877-022-03620-4.

    PMID: 36528769
  41. 41

    MGMT, a risk factor for both genetic and environmental forms of dementia.

    Kisby GE, Oakes H, Beckett D, Spencer PS

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2023; (19(5)):2208-2210 doi:10.1002/alz.12900.

    PMID: 36583449
  42. 42

    Palliative care principles in ALS.

    Shoesmith C

    Handbook of clinical neurology 2023; (191()):139-155 doi:10.1016/B978-0-12-824535-4.00007-0.

    PMID: 36599506
  43. 43

    Guam ALS-PDC is a distinct double-prion disorder featuring both tau and Aβ prions.

    Condello C, Ayers JI, Dalgard CL, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2023; (120(13)):e2220984120 doi:10.1073/pnas.2220984120.

    PMID: 36952379
  44. 44

    The experiences of patients with amyotrophic lateral sclerosis of their decision-making processes to invasive home mechanical ventilation-A qualitative study.

    Thorborg T, Finderup J, Winther DS, et al.

    Nursing open 2023; (10(8)):5139-5148 doi:10.1002/nop2.1749.

    PMID: 37071691
  45. 45

    Combined Tui na and Western medicine treatment improves pulmonary function and quality of life in patients with amyotrophic lateral sclerosis: A case report.

    Li B, Liu H, Li C, et al.

    Medicine 2023; (102(16)):e33612 doi:10.1097/MD.0000000000033612.

    PMID: 37083797
  46. 46

    What do people affected by amyotrophic lateral sclerosis want from health communications? Evidence from the ALS Talk Project.

    Genuis SK, Luth W, Bubela T, Johnston WS

    Muscle & nerve 2023; (68(3)):286-295 doi:10.1002/mus.27935.

    PMID: 37462337
  47. 47

    Accessing and Receiving Speech-Language Pathology Services at the Multidisciplinary Amyotrophic Lateral Sclerosis Clinic: An Exploratory Qualitative Study of Patient Experiences and Needs.

    Huynh A, Adams K, Barnett-Tapia C, et al.

    Journal of speech, language, and hearing research : JSLHR 2024; (67(10S)):4025-4037 doi:10.1044/2023_JSLHR-23-00087.

    PMID: 37678221
  48. 48

    [Parkinson-dementia and amyotrophic lateral sclerosis association (complex of Guam). Diagnostic challenge, Mexican patient].

    Aguilar-Vázquez CA, Gallardo-González LI, Raymundo-Carrillo AD, et al.

    Revista medica del Instituto Mexicano del Seguro Social 2023; (61(5)):677-684 doi:10.5281/zenodo.8316479.

    PMID: 37773166
  49. 49

    Exploring Advancements in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review of Current Modalities and Future Prospects.

    Hoxhaj P, Hastings N, Kachhadia MP, et al.

    Cureus 2023; (15(9)):e45489 doi:10.7759/cureus.45489.

    PMID: 37868386
  50. 50

    Prevention of Falls in Parkinson's Disease: Guidelines and Gaps.

    Camicioli R, Morris ME, Pieruccini-Faria F, et al.

    Movement disorders clinical practice 2023; (10(10)):1459-1469 doi:10.1002/mdc3.13860.

    PMID: 37868930
  51. 51

    Brait-Fahn-Schwartz Disease: A Unique Co-Occurrence of Parkinson's Disease and Amyotrophic Lateral Sclerosis.

    Aslam A, Sarmad E, Nawaz A, et al.

    Case reports in neurology 2023; (15(1)):207-214 doi:10.1159/000532092.

    PMID: 37901127
  52. 52

    Tau filaments from amyotrophic lateral sclerosis/parkinsonism-dementia complex adopt the CTE fold.

    Qi C, Verheijen BM, Kokubo Y, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2023; (120(51)):e2306767120 doi:10.1073/pnas.2306767120.

    PMID: 38100415
  53. 53

    Brain health: Pathway to primary prevention of neurodegenerative disorders of environmental origin.

    Spencer PS, Berntsson SG, Buguet A, et al.

    Journal of the neurological sciences 2025; (468()):123340 doi:10.1016/j.jns.2024.123340.

    PMID: 39667295
  54. 54

    Associations Between End-Stage ALS Care and Specialty Palliative Care: A Hypothesis-Generating Study.

    Lero CM, Yang A, Everett E, et al.

    Muscle & nerve 2025; (71(4)):632-638 doi:10.1002/mus.28370.

    PMID: 39936380
  55. 55

    Providing life-sustaining treatments at home for those with Motor Neurone Disease: A qualitative study of bereaved family members' experiences of responsibility.

    Wilson E, Palmer J, Kaltsakas G, et al.

    Palliative medicine 2025; (39(5)):584-593 doi:10.1177/02692163251327866.

    PMID: 40119769
  56. 56

    Barriers and strategies affecting the use of assistive devices for falls prevention among people with Parkinson's disease: a qualitative pilot study.

    Fernandes JB, Domingos J, Fernandes S, et al.

    BMC geriatrics 2025; (25(1)):352 doi:10.1186/s12877-025-06022-4.

    PMID: 40389856
  57. 57

    [Sporadic form of Guam disease (ALS-parkinsonism-dementia complex)].

    Kicherova OA, Doyan YI, Kicherova KP, et al.

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2025; (125(7)):135-141 doi:10.17116/jnevro2025125071135.

    PMID: 40760897
  58. 58

    Fall Prevention Interventions for Cognitively Impaired Older Adults: A Systematic Literature Review and Meta-Analysis.

    Choi H, H Tak S, Lee D

    Western journal of nursing research 2026; (48(1)):90-101 doi:10.1177/01939459251381979.

    PMID: 41104487
  59. 59

    SYNE1 Deficiency Manifesting Primarily With Motor Neuron Disease.

    Senghor HVF, Rubio RD, Marco C, et al.

    Neurology. Genetics 2025; (11(6)):e200306 doi:10.1212/NXG.0000000000200306.

    PMID: 41322345
  60. 60

    Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex (ALS/PDC) features CTE-like tau seeds in brain and spinal cord.

    Saez-Calveras N, Verheijen BM, Morgan N, et al.

    bioRxiv : the preprint server for biology 2025; doi:10.64898/2025.12.22.696002.

    PMID: 41509476
  61. 61

    Nursing a Patient With Amyotrophic Lateral Sclerosis Stage 4B With Epilepsy: A Case Study.

    Zhang R, Zhang N, Li B, et al.

    Nursing in critical care 2026; (31(4)):e70573 doi:10.1111/nicc.70573.

    PMID: 42461162